» Articles » PMID: 16963265

The Automatic Production of 16alpha-[18F]fluoroestradiol Using a Conventional [18F]FDG Module with a Disposable Cassette System

Overview
Date 2006 Sep 12
PMID 16963265
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

We have developed a fully automatic method for the synthesis of 16alpha-[18F]fluoroestradiol ([18F]FES) using a disposable cassette system and conventional [18F]FDG module. [18F]FES was synthesized using a GE TracerLab MX module and a modified module control program. Following [18F]fluorination, we hydrolyzed the product three times with a mixture of 2N HCl and CH(3)CN. After HPLC purification, the decay corrected radiochemical yield of [18F]FES was 45.3+/-2.8%, which was stable to 98.2+/-0.2% at 6h after synthesis. This new automated synthesis method provides high and reproducible yields with the advantage of a disposable cassette system.

Citing Articles

Predictive and prognostic value of F-FES PET/CT for patients with recurrent or metastatic breast cancer treated with endocrine therapy plus cyclin-dependent kinase 4/6 inhibitors.

Jeong H, Ryu J, Jeong J, Han S, Hyung J, Ahn J Eur J Nucl Med Mol Imaging. 2025; .

PMID: 39806206 DOI: 10.1007/s00259-024-07058-1.


In vivo brain estrogen receptor density by neuroendocrine aging and relationships with cognition and symptomatology.

Mosconi L, Nerattini M, Matthews D, Jett S, Andy C, Williams S Sci Rep. 2024; 14(1):12680.

PMID: 38902275 PMC: 11190148. DOI: 10.1038/s41598-024-62820-7.


Dynamic whole-body [F]FES PET/CT increases lesion visibility in patients with metastatic breast cancer.

Pedersen M, Munk O, Dias A, Steffensen J, Moller A, Johnsson A EJNMMI Res. 2024; 14(1):24.

PMID: 38436824 PMC: 10912074. DOI: 10.1186/s13550-024-01080-y.


Development and application of a fully automatic multi-function cassette module Mortenon M1 for radiopharmaceutical synthesis.

Cui F, Lv X, Yan C, Eng W, Yu S, Zheng Q Ann Nucl Med. 2023; 38(4):247-263.

PMID: 38145430 DOI: 10.1007/s12149-023-01893-2.


High-dose tamoxifen in high-hormone-receptor-expressing advanced breast cancer patients: a phase II pilot study.

Su Y, Zhang Y, Hua X, Huang J, Bi X, Xia W Ther Adv Med Oncol. 2021; 13:1758835921993436.

PMID: 33737962 PMC: 7934038. DOI: 10.1177/1758835921993436.